CryoPort (CYRX) vs Obsidian Therapeutics (OBX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
CryoPort is the larger company by market cap ($856.0 million vs $780.2 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CYRX | OBX |
|---|---|---|
| Share price | $16.90 | $12.63 |
| Market cap | $855.97M | $780.19M |
| 1-day change | -2.59% | -4.32% |
| YTD return | +80.73% | — |
| 1-year return | +77.04% | — |
| 5-year return | -75.31% | — |
| EPS (TTM) | $-0.81 | $-1.63 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $18.36 | $49.97 |
| 52-week low | $7.61 | $12.16 |
| Distance from 52-week high | -7.95% | -74.72% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +16.39% | +208.79% |
| Average volume | 632.63K | 364.47K |
| Shares outstanding | 50.65M | 61.77M |
| Employees | 684 | 87 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About CryoPort
CYRX stock →Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and reproductive medicine markets worldwide.
Health Care · Biotechnology: Pharmaceutical Preparations · 684 employees
About Obsidian Therapeutics
OBX stock →Obsidian Therapeutics, Inc. operates as a clinical-stage biotechnology company developing engineered cell and gene therapies.
Health Care · Biotechnology: Pharmaceutical Preparations · 87 employees
CYRX vs OBX FAQ
Which is bigger, CryoPort or Obsidian Therapeutics?
CryoPort (CYRX) is larger, with a market capitalization of $855.97M compared with $780.19M for Obsidian Therapeutics (OBX).
Are CryoPort and Obsidian Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.